Lite Strategy Inc 的流动比率是 18,净利 margin 为 0,每股销售为 $0。
Rivernorth/Doubleline Strategic Opportunity Fund Inc 的收入按细分市场或地理位置如何划分?
Lite Strategy Inc 最大收入来源是 Synthetic Biology Therapeutics,在最近的收益报告中收入为 3,371,000。就地区而言, United States 是 Lite Strategy Inc 的主要市场,收入为 3,371,000。
Rivernorth/Doubleline Strategic Opportunity Fund Inc 是否盈利?
不,根据最新的财务报表,Lite Strategy Inc 的净损失为 $-15
Rivernorth/Doubleline Strategic Opportunity Fund Inc 有负债吗?
是的,Lite Strategy Inc 的负债为 1
Rivernorth/Doubleline Strategic Opportunity Fund Inc 的流通股有多少?
Lite Strategy Inc 的总流通股为 6.66
关键数据
前收盘价
$18.4
开盘价
$18.38
当日区间
$18.18 - $18.38
52周范围
$7.49 - $18.18
交易量
--
平均成交量
123.5K
股息收益率
--
每股收益(TTM)
--
市值
$349.3M
什么是 OPP.PRB?
Rivernorth/Doubleline Strategic Opportunity Fund Inc is a US-based company operating in industry. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2016-09-28. RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund is a diversified investment company with an investment objective to seek current income and overall total return. Under normal market conditions no more than 20% of the Fund’s managed assets allocated to the Tactical Closed-End Fund Income Strategy is invested in equity underlying funds. The Fund may invest in underlying funds that invest in securities that are rated below investment grade. The company focuses on investing in sectors, including cash, non-agency mortgage collateralized mortgage obligations, bank loan, government agencies, mortgage-backed securities (MBS) and short-term investments. The Fund’s investment adviser, RiverNorth Capital Management, LLC its sub-advisor is DoubleLine Capital LP.